NI
SLN

Nextech Invest’s Silence Therapeutics SLN Stock Holding History

Nextech Invest’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.02M Hold
952,400
– – 0.35% 15
2025
Q4 		$5.79M Hold
952,400
– – 0.56% 15
2025
Q3 		$4.94M Hold
952,400
– – 0.75% 13
2025
Q2 		$5.52M Hold
952,400
– – 1.05% 13
2025
Q1 		$2.69M Hold
952,400
– – 0.62% 14
2024
Q4 		$6.55M Hold
952,400
– – 1.06% 14
2024
Q3 		$17.3M Hold
952,400
– – 2.43% 10
2024
Q2 		$18.1M Hold
952,400
– – 3.04% 10
2024
Q1 		$20.6M Buy
+952,400
New +$20.7M 3.26% 9

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Nextech Invest's SLN Position: Q1 2026 in Review

Nextech Invest held its Silence Therapeutics (SLN) position steady in Q1 2026 at 952,400 shares worth $5.02M. The position accounts for 0.35% of the portfolio, ranked #15.

Nextech Invest first reported a position in SLN in Q1 2024 and has held it in 9 quarters since. The position peaked at $20.6M in Q1 2024. 56 funds tracked by Wall St. Rank hold SLN as of Q1 2026.

  • Nextech Invest held 952,400 shares of Silence Therapeutics worth $5.02M as of Q1 2026.
  • Nextech Invest left its Silence Therapeutics share count unchanged in Q1 2026.
  • Silence Therapeutics made up 0.35% of Nextech Invest's portfolio in Q1 2026, its #15 holding.
  • Nextech Invest first reported a position in Silence Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Nextech Invest's Silence Therapeutics position peaked at $20.6M in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Silence Therapeutics as of Q1 2026.

Based on Nextech Invest's 13F filing for Q1 2026, filed 15 May 2026.